Morgan Stanley Asia

Morgan Stanley Private Equity Asia is a private equity investor in the Asia-Pacific region. It invests primarily in highly structured minority investments and control buyouts in growth-oriented companies.

Morgan Stanley Asia, established in 1993 and headquartered in New York, New York, United States, North America., specializes in Private Equity, Late Stage Venture, Seed, Early Stage Venture investments across Biotechnology, Health Care, Pharmaceutical, Biopharma, Venture Capital, Transportation, Manufacturing, Mechanical Engineering, Railroad, Industrial Manufacturing. The organization boasts a portfolio of 38 investments, with an average round size of $92.7M and 25 successful exits. Their recent investments include Buchang Pharma, GGV Capital, Jupiter Wagons, Ask Group, Edelweiss Mutual Fund. The highest investment round they participated in was $118.3B. Among their most notable exits are Buchang Pharma and GGV Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.